Literature DB >> 1372556

Interleukin-7 expression during mouse thymus development.

M V Wiles1, P Ruiz, B A Imhof.   

Abstract

We have monitored the expression of interleukin-7 (IL-7) in the developing embryonic mouse thymus by a combination of quantitative polymerase chain reaction (PCR) and immunofluorescence microscopy. A strong specific signal for IL-7 mRNA was detected by day 12 in the developing fetal thymus. IL-7 mRNA was found to be maximally expressed on day 15, and then decreased over the next 5 days. Immunofluorescence staining of fetal thymus sections using an anti-IL-7 antibody confirmed these PCR data. IL-7 protein expression was first detected at day 13 of development. At 14 days the intensity of the staining increased by a factor of three and stayed at this level over the next 4 days. The same anti-IL-7 antibody used for immunofluorescence, blocked the proliferation of fetal thymocytes in organotypic cultures. In addition, we detected mRNA coding for IL-2 and SCF (also known as the steel factor or KL) in embryonic thymocytes. The implications of these findings for early thymocyte growth are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372556     DOI: 10.1002/eji.1830220424

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  The serum factor from patients with ulcerative colitis that induces T cell proliferation in the mouse thymus is interleukin-7.

Authors:  M Watanabe; N Watanabe; Y Iwao; H Ogata; T Kanai; Y Ueno; M Tsuchiya; H Ishii; S Aiso; S Habu; T Hibi
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

2.  Interleukin-7 in the skin of Schistosoma mansoni-infected mice is associated with a decrease in interferon-gamma production and leads to an aggravation of the disease.

Authors:  I Wolowczuk; M Delacre; O Roye; S L Giannini; C Auriault
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

3.  Identification and characterization of thymus LIM protein: targeted disruption reduces thymus cellularity.

Authors:  J Kirchner; K A Forbush; M J Bevan
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

4.  Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo.

Authors:  J I Sin; J Kim; C Pachuk; D B Weiner; C Patchuk
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

5.  Interleukin-7 inhibits pre-T-cell differentiation induced by the pre-T-cell receptor signal and the effect is mimicked by hGM-CSF in hGM-CSF receptor transgenic mice.

Authors:  Yuko Yasuda; Azusa Kaneko; Ichiko Nishijima; Shoichiro Miyatake; Ken-Ichi Arai
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

6.  In vivo expression of interleukin-1 beta (IL-1 beta), IL-2, IL-4, IL-6, tumour necrosis factor-alpha and interferon-gamma in the fetal murine thymus.

Authors:  J Deman; M Van Meurs; E Claassen; C Humblet; J Boniver; M P Defresne
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

7.  Interleukin-7, a new cytokine targeting the mouse hypothalamic arcuate nucleus: role in body weight and food intake regulation.

Authors:  Laurence Macia; Odile Viltart; Myriam Delacre; Christelle Sachot; Laurent Héliot; James P Di Santo; Isabelle Wolowczuk
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

Review 8.  Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat.

Authors:  Holly M Kolenda-Roberts; Leah A Kuhnt; Ryan N Jennings; Ayalew Mergia; Nazareth Gengozian; Calvin M Johnson
Journal:  Front Biosci       Date:  2007-05-01

9.  Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes.

Authors:  M Watanabe; Y Ueno; T Yajima; Y Iwao; M Tsuchiya; H Ishikawa; S Aiso; T Hibi; H Ishii
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  Visualization and identification of IL-7 producing cells in reporter mice.

Authors:  Renata I Mazzucchelli; Søren Warming; Scott M Lawrence; Masaru Ishii; Mehrnoosh Abshari; A Valance Washington; Lionel Feigenbaum; Andrew C Warner; Davis J Sims; Wen Qing Li; Julie A Hixon; Daniel H D Gray; Benjamin E Rich; Matthew Morrow; Miriam R Anver; James Cherry; Dieter Naf; Lawrence R Sternberg; Daniel W McVicar; Andrew G Farr; Ronald N Germain; Keith Rogers; Nancy A Jenkins; Neal G Copeland; Scott K Durum
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.